These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 4945870)

  • 21. [Compatibility tests and pre-transfusion precautions].
    Andre A
    Acta Anaesthesiol Belg; 1970; 21(1):69-87. PubMed ID: 4997382
    [No Abstract]   [Full Text] [Related]  

  • 22. The preoperative assessment of histocompatibility.
    Zmijewski CM; Fletcher JL
    Arch Intern Med; 1969 May; 123(5):514-20. PubMed ID: 4888970
    [No Abstract]   [Full Text] [Related]  

  • 23. [Blood transfusion reaction (especially red cell incompatibility) and examinations for its protection (author's transl)].
    Tohyama H
    Rinsho Byori; 1980 Feb; 28(2):93-101. PubMed ID: 6767868
    [No Abstract]   [Full Text] [Related]  

  • 24. The current status of the HLA controversy in clinical transplantation.
    Rapaport FT
    Transplant Proc; 1995 Feb; 27(1):92. PubMed ID: 7879230
    [No Abstract]   [Full Text] [Related]  

  • 25. False blood group determination after massive incompatible blood transfusions.
    Doichinova N; Kourteva B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(3):323-5. PubMed ID: 4193008
    [No Abstract]   [Full Text] [Related]  

  • 26. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
    Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
    Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventing the incompatible blood transfusion.
    Tovey GH
    Haematologia (Budap); 1974; 8(1-4):389-91. PubMed ID: 4218824
    [No Abstract]   [Full Text] [Related]  

  • 28. [The selection of organ recipients according to the ABO blood group match. Theory and practice].
    Speiser P
    Wien Klin Wochenschr; 1985 Nov; 97(22):848-50. PubMed ID: 3909652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue transplantation-the universal donor and blood group antibodies.
    Camp FR; Kaplan HS; Ellis FR; Zmijewski CM; Conte NF
    J Forensic Sci; 1970 Oct; 15(4):500-6. PubMed ID: 4924113
    [No Abstract]   [Full Text] [Related]  

  • 30. An ABO incompatible sibling as rescue kidney donor.
    Blohmé I; Mjörnstedt L; Rydberg L; Nyberg G; Tufveson G
    Transplant Proc; 1994 Jun; 26(3):1745. PubMed ID: 8030115
    [No Abstract]   [Full Text] [Related]  

  • 31. ABO blood group incompatibility in human renal homotransplantation.
    Wilbrandt R; Tung KS; Deodhar SD; Nakamoto S; Kolff WJ
    Am J Clin Pathol; 1969 Jan; 51(1):15-23. PubMed ID: 4885605
    [No Abstract]   [Full Text] [Related]  

  • 32. [Human histocompatibility].
    Colombani J; Dausset J
    Pathol Biol (Paris); 1969 Mar; 17(5):281-99. PubMed ID: 4239837
    [No Abstract]   [Full Text] [Related]  

  • 33. [Irregular erythrocytic antibodies as an obstacle to transfusion].
    Uhlig R; Endert G; Lammel G
    Z Arztl Fortbild (Jena); 1984; 78(20):849-52. PubMed ID: 6523909
    [No Abstract]   [Full Text] [Related]  

  • 34. Impact of retransplant status on delayed graft function: an analysis of paired cadaver kidneys.
    Conti DJ; Freed BM; Gruber SA; Singh TP; Gallichio M; Lempert N
    Transplant Proc; 1995 Feb; 27(1):1070-1. PubMed ID: 7878809
    [No Abstract]   [Full Text] [Related]  

  • 35. [The role of blood group compatibility in corneal transplantation].
    Mailáth L; Stenszky V; Alberth B; Aszódi L
    Klin Monbl Augenheilkd; 1972 May; 160(5):550-3. PubMed ID: 4561733
    [No Abstract]   [Full Text] [Related]  

  • 36. The development of tissue typing.
    Converse JM; Rapaport FT
    Plast Reconstr Surg; 1969 Jul; 44(1):9-19. PubMed ID: 4893017
    [No Abstract]   [Full Text] [Related]  

  • 37. The value of present methods used for the selection of organ donors.
    Hamburger J; Crosnier J; Descamps B; Rowinska D
    Transplant Proc; 1971 Mar; 3(1):260-7. PubMed ID: 4106322
    [No Abstract]   [Full Text] [Related]  

  • 38. Hyperacute renal allograft rejection in the human neonate.
    Lawson RK; Bennett WM; Campbell RA; Pirofsky B; Hodges CV
    Invest Urol; 1973 May; 10(6):444-9. PubMed ID: 4574276
    [No Abstract]   [Full Text] [Related]  

  • 39. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components.
    Rowley SD; Liang PS; Ulz L
    Bone Marrow Transplant; 2000 Oct; 26(7):749-57. PubMed ID: 11042656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemolytic anemia in cyclosporine-treated recipients of kidney or heart grafts from donors with minor incompatibility for ABO antigens.
    Solheim BG; Albrechtsen DA; Berg KJ; Flatmark A; Fauchald P; Frøysaker T; Geiran O; Jakobsen A; Lindberg H; Pfeffer P
    Transplant Proc; 1987 Oct; 19(5):4236-8. PubMed ID: 3314021
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.